Literature DB >> 954007

Chemistry and structure-activity studies of the nitrosoureas.

J A Montgomery.   

Abstract

The N-nitrosoureas are the most active of a variety of N-nitroso compounds tested against L1210 leukemia in mice. Structure-activity studies show that the N-(2-chloro(or fluoro)ethyl)-N-nitrosoureido grouping is necessary for high-level activity in this test system, but a variety of carrier groups can be attached to the N'-nitrogen of the urea. For high-level activity against solid tumors in rodents, eg, the Lewis lung adenocarcinoma, the N'-substituent must be a cyclohexane ring, and the most active of these compounds are substituted at position 4 of the ring. The chemistry involved in the synthesis and reactions of the nitrosoureas is described. The possible relationship of the chemically reactive species generated by the decomposition of the nitrosoureas under in vivo conditions to biologic activity is discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 954007

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  10 in total

1.  CGP 6809--a new nitrosoureido-sugar derivative with activity in human tumor xenografts.

Authors:  H H Fiebig; K H Widmer; B R Winterhalter; G W Löhr
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  DNA crosslinking and cytotoxicity in normal and transformed human cells treated with antitumor nitrosoureas.

Authors:  L C Erickson; M O Bradley; J M Ducore; R A Ewig; K W Kohn
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

3.  Vinylchloride: decomposition product of BCNU in vivo and in vitro.

Authors:  M R Clemens; H Frank; H Remmer; H D Waller
Journal:  Cancer Chemother Pharmacol       Date:  1982-12       Impact factor: 3.333

4.  Genotoxic and cytotoxic effects of 4-aroyl-1-nitrosohydrazine-carboxamides on O6-alkylguanine-DNA alkyltransferase-positive and -negative human cell lines.

Authors:  C Schell; O Lantermann; W Popp; C Vahrenholz; J Thomale; R Gugova; E Golovinsky; K Norpoth
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

5.  Differential distribution and covalent binding of two labeled forms of methyl-CCNU in the Fischer 344 rat.

Authors:  R A Kramer; M G McMenamin; M R Boyd
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

6.  Membrane and cytoplasmic changes in 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU)-sensitive and resistant human malignant glioma-derived cell lines.

Authors:  B H Smith; M Vaughan; M A Greenwood; P L Kornblith; A Robinson; N Shitara; P E McKeever
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

7.  The level of DNA interstrand crosslinking in bone marrow parallels the extent of myelosuppression in mice treated with four chloroethylnitrosoureas.

Authors:  P Bedford; M R Berger; G Eisenbrand; D Schmähl
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

8.  Chemical stability of ecomustine, a new antitumor agent in aqueous and biological media as assessed by high-performance liquid chromatography.

Authors:  I el Abed; P Roger; C Gosse; G Atassi; A Gouyette
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

9.  Relationship between DNA damage and the inhibition of stem cells in murine bone marrow after single and repeated administration of BCNU and HECNU.

Authors:  M R Berger; T Henne; P Bedford
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

10.  Repair of O6-(2-chloroethyl)guanine mediates the biological effects of chloroethylnitrosoureas.

Authors:  W J Bodell; T Aida; M S Berger; M L Rosenblum
Journal:  Environ Health Perspect       Date:  1985-10       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.